{
    "clinical_study": {
        "@rank": "45168", 
        "arm_group": [
            {
                "arm_group_label": "CCB", 
                "description": "Patients receiving calcium channel blockers (CCB)"
            }, 
            {
                "arm_group_label": "ACEi", 
                "description": "Patients receiving angiotensin converting enzyme inhibitors (ACEi)"
            }, 
            {
                "arm_group_label": "CCB and ACEi", 
                "description": "Patients receiving calcium channel blockers (CCB) and angiotensin converting enzyme inhibitors (ACEi)"
            }, 
            {
                "arm_group_label": "No treatment", 
                "description": "Patients not receiving calcium channel blockers (CCB) and/or angiotensin converting enzyme inhibitors (ACEi)"
            }
        ], 
        "brief_summary": {
            "textblock": "Systemic sclerosis is an orphan, multiorgan disease affecting the connective tissue of the\n      skin and all internal organs. Cardiac involvement, mainly characterised by small\n      intramyocardial coronary artery involvement and myocardial fibrosis, can cause the\n      development of impaired diastolic ventricular filling, cardiac blocks and ventricular\n      arrhythmias, and can ensue in  congestive heart failure and sudden death. Until now, no drug\n      has been proven to have a therapeutic effect on SSc myocardial disease on an evidence-based\n      level. Short-term trials and retrospective studies have suggested a favourable and\n      protective effect of calcium channel blockers and angiotensin converting enzyme inhibitors\n      in patients with myocardial involvement. However, no data are presently available on the\n      prevention and treatment of severe heart disease.\n\n      This observational trial is part of the collaborative project \"DeSScipher\", one out of five\n      observational trials to decipher the optimal management of systemic sclerosis. Aim of this\n      observational trial is to assess the efficacy and safety of calcium channel blockers and\n      angiotensin converting enzyme inhibitors in asymptomatic SSc patients with cardiac\n      involvement."
        }, 
        "brief_title": "Development and Prevention of Severe Heart Disease in Systemic Sclerosis", 
        "completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Systemic Sclerosis", 
            "Cardiac Diseases", 
            "Heart Block", 
            "Cardiac Arrhythmia", 
            "Congestive Heart Failure"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Arrhythmias, Cardiac", 
                "Heart Block", 
                "Heart Diseases", 
                "Heart Failure", 
                "Scleroderma, Systemic", 
                "Scleroderma, Diffuse", 
                "Sclerosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Juvenile and adult systemic sclerosis patients, with diagnosis according to the SSc\n             ACR/EULAR criteria or the PRES/ACR/EULAR juvenile SSc criteria respectively\n\n          -  Asymptomatic (for cardiac disease) systemic sclerosis patients at risk for severe\n             heart disease with at least one of the following risk factors: male sex and/or DLCO\n             lower than 80% and/or sPAP > 30 mmHg and/or synovitis and/or joint contractures\n             and/or digital ulcers and/or proteinuria.\n\n        Asymptomatic for cardiac disease is defined by patients without dyspnea NYHA >/= II,\n        without palpitations and without bilateral leg edema.\n\n        Exclusion Criteria:\n\n          -  Any significant pulmonary parenchymal (FVC < 70% and/or DLCO < 70%), pulmonary\n             vascular (estimated systolic PAP > 40 mmHg), gastrointestinal (malabsorption syndrome\n             or paralytic ileus) or renal (serum creatinine level >1.2 mg/dl, dialysis or previous\n             scleroderma renal crisis) involvement\n\n          -  Patients with dyspnea class NYHA >/= II\n\n          -  Patients with palpitations\n\n          -  Patients with bilateral leg edema."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "The study population are adult and juvenile SSc patients from the EUSTAR cohort\n        (MEDSonline database) and the jSScWG cohort"
            }
        }, 
        "enrollment": {
            "#text": "765", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01829126", 
            "org_study_id": "HEALTH-F5-2012-305495-OT5"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Angiotensin-Converting Enzyme Inhibitors", 
                "Calcium Channel Blockers"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 7, 2013", 
        "link": {
            "url": "http://www.desscipher.eu"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75014"
                    }, 
                    "name": "Universit\u00e9 Paris Descartes, H\u00f4pital Cochin, Service de Rhumatologie A & INSERM 1016"
                }, 
                "investigator": {
                    "last_name": "Yannick Allanore, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bad Nauheim", 
                        "country": "Germany", 
                        "zip": "61231"
                    }, 
                    "name": "Justus-Liebig-University Gie\u00dfen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology"
                }, 
                "investigator": [
                    {
                        "last_name": "Ulf M\u00fcller-Ladner, Prof.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Ingo H. Tarner, Dr.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Marc Frerix, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "10117"
                    }, 
                    "name": "Charit\u00e9 Universit\u00e4tsmedizin Berlin, Charit\u00e9 Centrum 12 f\u00fcr Innere Medizin und Dermatologie, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie"
                }, 
                "investigator": {
                    "last_name": "Gabriela Riemekasten, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany", 
                        "zip": "22081"
                    }, 
                    "name": "Centre for Pediatric Rheumatology, Klinikum Eilbek"
                }, 
                "investigator": {
                    "last_name": "Ivan Foeldvari, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pecs", 
                        "country": "Hungary", 
                        "zip": "H-7622"
                    }, 
                    "name": "Pecsi Tudomanyegyetem - University of Pecs"
                }, 
                "investigator": {
                    "last_name": "Laszlo Czirjak, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Firenze", 
                        "country": "Italy", 
                        "zip": "50139"
                    }, 
                    "name": "University of Florence, Denothe Centre, Division of Rheumatology AOUC, Department of Biomedicine"
                }, 
                "investigator": {
                    "last_name": "Marco Matucci-Cerinic, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Napoli-Italia", 
                        "country": "Italy", 
                        "zip": "5-80131"
                    }, 
                    "name": "Policlinico, Via Pansini"
                }, 
                "investigator": {
                    "last_name": "Gabriele Valentini, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Basel", 
                        "country": "Switzerland", 
                        "zip": "CH 4012"
                    }, 
                    "name": "Felix-Platter Spital, University of Basel"
                }, 
                "investigator": {
                    "last_name": "Ulrich Walker, Prof", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zurich", 
                        "country": "Switzerland", 
                        "zip": "8006"
                    }, 
                    "name": "University of Zurich, Department of Rheumatology"
                }, 
                "investigator": {
                    "last_name": "Oliver Distler, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leeds", 
                        "country": "United Kingdom", 
                        "zip": "LS9 7TF"
                    }, 
                    "name": "The Universitiy of Leeds, Division of Rheumatic and Musculoskeletal Disease, St James's University Hospital"
                }, 
                "investigator": {
                    "last_name": "Francesco Del Galdo, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "NW3 2QG"
                    }, 
                    "name": "Royal Free Hospital, University College London"
                }, 
                "investigator": {
                    "last_name": "Christopher Denton, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "Germany", 
                "Hungary", 
                "Italy", 
                "Switzerland", 
                "United Kingdom"
            ]
        }, 
        "number_of_groups": "4", 
        "other_outcome": {
            "measure": "Incidence of drug-related adverse events, incidence of withdrawal from treatment due to drug-related adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "1 year"
        }, 
        "overall_contact": {
            "email": "gabriele.valentini@unina2.it", 
            "last_name": "Gabriele Valentini, Prof.", 
            "phone": "39815464487"
        }, 
        "overall_official": [
            {
                "affiliation": "Justus-Liebig-University Gie\u00dfen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology", 
                "last_name": "Ulf M\u00fcller-Ladner, Prof.", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Policlinico, Via Pansini, Napoli-Italia", 
                "last_name": "Gabriele Valentini, Prof.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Italy: Ethics Committee", 
                "Germany: Ethics Commission", 
                "Hungary: Institutional Ethics Committee", 
                "France: Institutional Ethical Committee", 
                "Switzerland: Ethikkommission", 
                "United Kingdom: Research Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Cumulative incidence of cardiac blocks, ventricular arrhythmias, pacemaker implantation, congestive heart failure and sudden death.", 
            "measure": "Cumulative incidence of CB, VA, pacemaker implantation, congestive heart failure and sudden death", 
            "safety_issue": "No", 
            "time_frame": "1 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01829126"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Second University of Naples", 
            "investigator_full_name": "Gabriele Valentini", 
            "investigator_title": "Prof. Gabriele Valentini", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Second University of Naples", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "European Union", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Giessen", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Zurich", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Paris 5 - Rene Descartes", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Florence", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Basel", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University College, London", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Charite University, Berlin, Germany", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Pecs", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Leeds", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Schoen Klinik Hamburg Eilbek", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Gabriele Valentini", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "1 Year", 
        "verification_date": "November 2013"
    }
}